Quality indicators related to the overall management
| QI 3 - Center participating in ongoing clinical trials in gynecological cancer | |
| Type | Structural indicator |
| Description | The center actively accrues patients in ongoing clinical trials (not restricted to surgery) in gynecological cancer |
| Specifications |
Numerator: number of ongoing clinical trials in gynecological cancer (not restricted to surgery only) Denominator: not applicable |
| Target | ≥1 |
| QI 4 - Treatment discussed at a multi-disciplinary team meeting | |
| Type | Process indicator |
| Description | The decision for any therapeutic intervention (excluding any diagnostic procedure—that is, biopsies or conization performed with a diagnostic intent) has been taken by a multi-disciplinary team including at least a gynecologic oncologist or a trained surgeon specifically dedicated to gynecological cancer as defined above (quality indicator 2), a radiologist, a radiation oncologist, a medical or clinical oncologist, and a pathologist |
| Specifications |
Numerator: number of patients with cervical cancer for whom the decision for any therapeutic intervention has been made by a multi-disciplinary team Denominator: all patients presenting with cervical cancer |
| Target | 100% |
| QI 5 - Required pre-operative investigation | |
| Type | Process indicator |
| Description | The required pre-operative investigation is defined according to the ESGO-ESTRO-ESP guidelines5–7 |
| Specifications |
Numerator: number of patients with cervical cancer for whom surgery is planned who received pre-operative investigation according to the ESGO-ESTRO-ESP guidelines5–7
Denominator: all patients with cervical cancer for whom surgery is planned |
| Target | 100%* |
*Need to specify if the required pre-operative investigation, defined according to the ESGO-ESTRO-ESP guidelines,5–7 is not followed